State Key Laboratory of Brain and Cognitive Science, Institute of Biophysics, University of Chinese Academy of Sciences, Beijing 100101, China.
Southwest Medical University, Luzhou, Sichuan 646000, China.
EBioMedicine. 2017 Nov;25:143-153. doi: 10.1016/j.ebiom.2017.10.001. Epub 2017 Oct 5.
Glycated haemoglobin (HbA1c) is the most important marker of hyperglycaemia in diabetes mellitus. We show that d-ribose reacts with haemoglobin, thus yielding HbA1c. Using mass spectrometry, we detected glycation of haemoglobin with d-ribose produces 10 carboxylmethyllysines (CMLs). The first-order rate constant of fructosamine formation for d-ribose was approximately 60 times higher than that for d-glucose at the initial stage. Zucker Diabetic Fatty (ZDF) rat, a common model for type 2 diabetes mellitus (T2DM), had high levels of d-ribose and HbA1c, accompanied by a decrease of transketolase (TK) in the liver. The administration of benfotiamine, an activator of TK, significantly decreased d-ribose followed by a decline in HbA1c. In clinical investigation, T2DM patients with high HbA1c had a high level of urine d-ribose, though the level of their urine d-glucose was low. That is, d-ribose contributes to HbA1c, which prompts future studies to further explore whether d-ribose plays a role in the pathophysiological mechanism of T2DM.
糖化血红蛋白(HbA1c)是糖尿病患者血糖升高的最重要标志物。我们发现,d-核糖与血红蛋白反应,从而生成 HbA1c。通过质谱分析,我们检测到血红蛋白与 d-核糖的糖化反应生成了 10 个羧甲基赖氨酸(CML)。在初始阶段,d-核糖形成果糖胺的一级速率常数比 d-葡萄糖大约高 60 倍。Zucker 糖尿病肥胖(ZDF)大鼠是 2 型糖尿病(T2DM)的常用模型,其体内含有大量的 d-核糖和 HbA1c,同时伴有肝脏中转酮醇酶(TK)活性降低。TK 的激活剂苯磷硫胺(benfotiamine)的给药显著降低了 d-核糖,随后 HbA1c 也下降。在临床研究中,HbA1c 水平较高的 T2DM 患者尿液中的 d-核糖水平较高,尽管他们尿液中的 d-葡萄糖水平较低。也就是说,d-核糖导致了 HbA1c 的升高,这促使未来的研究进一步探讨 d-核糖是否在 T2DM 的病理生理机制中发挥作用。